Skip to main content
. 2023 Dec 2;15:100419. doi: 10.1016/j.jvacx.2023.100419

Fig. 1.

Fig. 1

Observed/Expected analyses for selected AESIs with mRNA vaccination Primary series for vaccines aged 12 years and above with two distinct risk period definitions. All cases in the ‘Day 0 to Day 21′ analyses are also included in the ‘Day 0 to Day 42′ analyses.